SlideShare a Scribd company logo
PROSPERO: an international prospective
register of systematic review protocols


  Alison Booth Mike Clarke Davina Ghersi David Moher
             Mark Petticrew Lesley Stewart
Prospective registration of systematic
review protocols

•   PRISMA 2009 advocated registration
•   CRD initiated development of PROSPERO

•   PROSPERO launched 2011
•   Until then no open access facility to formally register systematic
    review protocols
•   Although publication of protocols is integral to Cochrane and
    Campbell Collaborations this is limited to their own
    organisations
Why register systematic reviews


•   Widely accepted (& promoted) that systematic reviews provide
    best evidence for decision making

•   Have the potential to impact on decisions that affect the care of
    many people and to have significant budgetary impact

•   Associated responsibility to ensure best methods and conduct to
    ensure systematic reviews are robust and free from bias
Avoiding bias

•   Detecting and mitigating bias in included studies is central to
    systematic review. Influences and pressures on reporting are
    the same for systematic reviews as for clinical trials
•   Systematic review protocols ensure review methods are
    transparent and reproducible. Adherence to the protocol should
    help avoid bias
•   Changes in emphasis between protocol and completed review
    have potential to bias review findings
•   Evidence that reviews change between protocol and final report
    (Silagy et al JAMA 2002) and of outcome reporting biases
    (Kirkham et al PLoS ONE 2010)
Registration can help


•   Permanent public record of key elements of planned review
    including inclusion criteria and outcomes

•   Allows amendments and maintains audit trail of changes
    (not unreasonable to make changes, but need to know why)


•   Allows published results to be compared with what was planned
    at protocol registration and judgement of whether any
    discrepancies might have introduced bias
Avoiding bias


•   Registration in PROSPERO takes place when the protocol is
    finalised but ideally before eligibility screening has started
•   Reduces opportunity for post-hoc „tweaking‟
•   Recognise that it will not stop deliberate „cheating‟
    • PROSPERO openly displays dates and amendments
    • Does not in itself prevent overt misuse
    • Falsification would be deliberate act of scientific misconduct
       with potentially serious and damaging consequences
Avoiding unintended duplication


•   Systematic reviews can be time consuming and costly
•   Often duplicate or very similar reviews are undertaken
•   Unintended duplication is economically wasteful

•   Commissioners and researchers may be unaware of ongoing
    reviews and/or unpublished reviews
How registration can help


•   Registration should allow those planning reviews to check
    whether there are any reviews already in the „pipeline‟ or
    completed but unpublished that address their topic of interest

•   They can then decide whether or not to proceed
Benefits to stakeholders

Researchers
• Comply with PRISMA
• Provide a public record of their planned methods
• Raise awareness of their review
• Unique registration number may help track subsequent use of
  their review and monitor impact

Commissioners and funders
• Identify ongoing and unpublished reviews
• Avoid unplanned duplication and economic wastefulness
Benefits to stakeholders

Guideline developers
• Information about forthcoming reviews may assist in planning
  and timing of guideline development

Journal Editors
• Safeguard against reporting biases
• Access to key protocol features to utilise in peer review

Peer reviewers
• Comparison of manuscript findings with the review protocol
Benefits to stakeholders


Methodologists
• Provides opportunity for methods research

The public
• Helps ensure that health and social care decisions that may
  affect them are known to be based on good quality systematic
  review evidence
• Open access information about ongoing systematic reviews
• Encourages transparency in the systematic review process
• Helping to avoid wasting money on unintended duplication
PROSPERO implementation
Aimed to make registration as straightforward as possible:

•   Web based
•   Free to register, free to search
•   Researchers create and update their own records
•   Record content is responsibility of researcher/ review author
•   Administrators check for “sense” not peer review
•   Issues unique registration number
•   An audit trail of amendments is maintained
•   Registration record indexed by the PROSPERO team
•   Based on data set agreed by international consultation:
    22 required fields 18 optional fields
Registering a review               www.crd.york.ac.uk/PROSPERO



Current scope

Systematic reviews of the
effects of interventions and
strategies to prevent, diagnose,
treat, and monitor health
conditions, for which there is a
health related outcome
PROSPERO

•   Since launch almost 600 reviews registered undertaken in 34
    different countries

•   Over 15,000 visitors and over a million page views in first year
Registration makes sense


•   Promotes transparency and helps identify and reduce risk of
    reporting bias
•   Helps avoid unintended duplication and supports research
    funding to be used wisely and to best effect
•   Requires modest additional effort and early success of
    PROSPERO indicates researchers are ready and willing to
    register their systematic review protocols
•   Prospective registration should become standard best practice
    for those who commission, fund and conduct systematic reviews
Thank you

The development and ongoing management of
PROSPERO is supported by CRD‟s core work programme
which is funded by the National Institute for Health
Research, England; the Department of Health, Public
Health Agency, Northern Ireland and the National Institute
for Social Care and Health Research, Welsh Government.



  www.crd.york.ac.uk/PROSPERO
     crd-register@york.ac.uk
Registration minimum dataset 22 required fields:


Administrative                                        Review design
•    Review title                                     •   Review question/objective
•    Named contact(s)                                 •   Condition/domain studied
•    Contact e-mail                                   •   Search details
•    Organisational affiliation                       •   Participants/population
•    Funding source/sponsors                          •   Intervention/exposure
•    Conflict of interests                            •   Comparator/control
•    Anticipated or actual start date                 •   Study types
•    Stage of review†                                 •   Primary outcomes
•    Anticipated completion date                      •   Secondary outcomes
•    Review status†                                   •   Risk of bias/quality assessment
                                                      •   Strategy for data synthesis
† these fields are updated as the review progresses   •   Planned subgroup analyses
Registration dataset 18 optional fields:

Administrative                           Review design
•   Contact postal address               •   Type of review
•   Contact phone number                 •   URL to search strategy
•   Review team members & affiliations   •   URL to full protocol
•   Collaborators                        •   Context
•   Other registration details           •   Data extraction methods
•   Organisational reference number      •   Dissemination plan
•   Language                             •   Link to final report/publication (added
•   Country                                  over time)
•   Key words
•   Any other information                    Italics denote functional fields not
•   Existing review by same authors          decided by consultation exercise

More Related Content

What's hot

Kappa statistics
Kappa statisticsKappa statistics
Kappa statistics
AmeyDhatrak
 
Introduction to meta-analysis (1612_MA_workshop)
Introduction to meta-analysis (1612_MA_workshop)Introduction to meta-analysis (1612_MA_workshop)
Introduction to meta-analysis (1612_MA_workshop)
Ahmed Negida
 
Overview of systematic review and meta analysis
Overview of systematic review and meta  analysisOverview of systematic review and meta  analysis
Overview of systematic review and meta analysis
Drsnehas2
 
Power, Effect Sizes, Confidence Intervals, & Academic Integrity
Power, Effect Sizes, Confidence Intervals, & Academic IntegrityPower, Effect Sizes, Confidence Intervals, & Academic Integrity
Power, Effect Sizes, Confidence Intervals, & Academic Integrity
James Neill
 
Scientific Studies Reporting Guidelines
Scientific Studies Reporting GuidelinesScientific Studies Reporting Guidelines
Scientific Studies Reporting Guidelines
Cognibrain Healthcare
 
Meta analysis
Meta analysisMeta analysis
Meta analysis
Dinesh Chaurasiya
 
Systematic review and meta analaysis course - part 1
Systematic review and meta analaysis course - part 1Systematic review and meta analaysis course - part 1
Systematic review and meta analaysis course - part 1
Ahmed Negida
 
Forest plot interpretation
Forest plot interpretationForest plot interpretation
Forest plot interpretation
Kenzie Trance
 
Data extraction/coding and database structure in meta-analysis
Data extraction/coding and database structure in meta-analysisData extraction/coding and database structure in meta-analysis
Data extraction/coding and database structure in meta-analysis
Rizwan S A
 
Sensitivity and specificity
Sensitivity and specificitySensitivity and specificity
Sensitivity and specificity
messi1910
 
Sensitivity, specificity, positive and negative predictive
Sensitivity, specificity, positive and negative predictiveSensitivity, specificity, positive and negative predictive
Sensitivity, specificity, positive and negative predictive
Musthafa Peedikayil
 
How to Identify the Research Gap While Writing a PhD Dissertation Literature ...
How to Identify the Research Gap While Writing a PhD Dissertation Literature ...How to Identify the Research Gap While Writing a PhD Dissertation Literature ...
How to Identify the Research Gap While Writing a PhD Dissertation Literature ...
PhD Assistance
 
PICO question
PICO questionPICO question
PICO question
IAU Dent
 
How to read a receiver operating characteritic (ROC) curve
How to read a receiver operating characteritic (ROC) curveHow to read a receiver operating characteritic (ROC) curve
How to read a receiver operating characteritic (ROC) curve
Samir Haffar
 
Sample size calculation in medical research
Sample size calculation in medical researchSample size calculation in medical research
Sample size calculation in medical research
Kannan Iyanar
 
Evaluating a diagnostic test presentation www.eyenirvaan.com - part 2
Evaluating a diagnostic test presentation www.eyenirvaan.com - part 2Evaluating a diagnostic test presentation www.eyenirvaan.com - part 2
Evaluating a diagnostic test presentation www.eyenirvaan.com - part 2
Eyenirvaan
 
Meta analysis: Made Easy with Example from RevMan
Meta analysis: Made Easy with Example from RevManMeta analysis: Made Easy with Example from RevMan
Meta analysis: Made Easy with Example from RevMan
Gaurav Kamboj
 
Bias and confounding
Bias and confoundingBias and confounding
Bias and confounding
Ikram Ullah
 
biostatistics basic
biostatistics basic biostatistics basic
biostatistics basic
jjm medical college
 

What's hot (20)

Kappa statistics
Kappa statisticsKappa statistics
Kappa statistics
 
Introduction to meta-analysis (1612_MA_workshop)
Introduction to meta-analysis (1612_MA_workshop)Introduction to meta-analysis (1612_MA_workshop)
Introduction to meta-analysis (1612_MA_workshop)
 
Overview of systematic review and meta analysis
Overview of systematic review and meta  analysisOverview of systematic review and meta  analysis
Overview of systematic review and meta analysis
 
Power, Effect Sizes, Confidence Intervals, & Academic Integrity
Power, Effect Sizes, Confidence Intervals, & Academic IntegrityPower, Effect Sizes, Confidence Intervals, & Academic Integrity
Power, Effect Sizes, Confidence Intervals, & Academic Integrity
 
Scientific Studies Reporting Guidelines
Scientific Studies Reporting GuidelinesScientific Studies Reporting Guidelines
Scientific Studies Reporting Guidelines
 
Meta analysis
Meta analysisMeta analysis
Meta analysis
 
Systematic review and meta analaysis course - part 1
Systematic review and meta analaysis course - part 1Systematic review and meta analaysis course - part 1
Systematic review and meta analaysis course - part 1
 
Forest plot interpretation
Forest plot interpretationForest plot interpretation
Forest plot interpretation
 
Data extraction/coding and database structure in meta-analysis
Data extraction/coding and database structure in meta-analysisData extraction/coding and database structure in meta-analysis
Data extraction/coding and database structure in meta-analysis
 
Sensitivity and specificity
Sensitivity and specificitySensitivity and specificity
Sensitivity and specificity
 
Sensitivity, specificity, positive and negative predictive
Sensitivity, specificity, positive and negative predictiveSensitivity, specificity, positive and negative predictive
Sensitivity, specificity, positive and negative predictive
 
How to Identify the Research Gap While Writing a PhD Dissertation Literature ...
How to Identify the Research Gap While Writing a PhD Dissertation Literature ...How to Identify the Research Gap While Writing a PhD Dissertation Literature ...
How to Identify the Research Gap While Writing a PhD Dissertation Literature ...
 
PICO question
PICO questionPICO question
PICO question
 
How to read a receiver operating characteritic (ROC) curve
How to read a receiver operating characteritic (ROC) curveHow to read a receiver operating characteritic (ROC) curve
How to read a receiver operating characteritic (ROC) curve
 
Sample size calculation in medical research
Sample size calculation in medical researchSample size calculation in medical research
Sample size calculation in medical research
 
Evaluating a diagnostic test presentation www.eyenirvaan.com - part 2
Evaluating a diagnostic test presentation www.eyenirvaan.com - part 2Evaluating a diagnostic test presentation www.eyenirvaan.com - part 2
Evaluating a diagnostic test presentation www.eyenirvaan.com - part 2
 
Meta analysis: Made Easy with Example from RevMan
Meta analysis: Made Easy with Example from RevManMeta analysis: Made Easy with Example from RevMan
Meta analysis: Made Easy with Example from RevMan
 
Bias and confounding
Bias and confoundingBias and confounding
Bias and confounding
 
biostatistics basic
biostatistics basic biostatistics basic
biostatistics basic
 
PICO Research Question
PICO Research QuestionPICO Research Question
PICO Research Question
 

Viewers also liked

Epinor abstract book 2014
Epinor abstract book 2014Epinor abstract book 2014
Epinor abstract book 2014
kgr023
 
Statistical Writing (Sven Sandin)
Statistical Writing (Sven Sandin)Statistical Writing (Sven Sandin)
Statistical Writing (Sven Sandin)
kgr023
 
Como hacer un avatar
Como hacer un avatarComo hacer un avatar
Como hacer un avatar
Adolfo Herrera
 
Information retrieval in systematic reviews: a case study of the crime preven...
Information retrieval in systematic reviews: a case study of the crime preven...Information retrieval in systematic reviews: a case study of the crime preven...
Information retrieval in systematic reviews: a case study of the crime preven...
Lisa Tompson
 
Cochrane Collaboration - Register of Studies Consultation
Cochrane Collaboration - Register of Studies ConsultationCochrane Collaboration - Register of Studies Consultation
Cochrane Collaboration - Register of Studies Consultation
Cochrane.Collaboration
 
1. Opening of the Austrian Cochrane Branch - Iain Chalmers
1. Opening of the Austrian Cochrane Branch - Iain Chalmers1. Opening of the Austrian Cochrane Branch - Iain Chalmers
1. Opening of the Austrian Cochrane Branch - Iain Chalmers
Cochrane.Collaboration
 
Systematic review searches
Systematic review searchesSystematic review searches
Systematic review searchesmarkmac
 
A mid flight correction: setting priorities
A mid flight correction: setting prioritiesA mid flight correction: setting priorities
A mid flight correction: setting prioritiesCochrane.Collaboration
 
Exhaustive Literature Searching (Systematic Reviews)
Exhaustive Literature Searching (Systematic Reviews)Exhaustive Literature Searching (Systematic Reviews)
Exhaustive Literature Searching (Systematic Reviews)
markmac
 
Crowdsourcing and Cochrane
Crowdsourcing and CochraneCrowdsourcing and Cochrane
Crowdsourcing and Cochrane
Cochrane.Collaboration
 
Systematic review intro for librarians
Systematic review intro for librariansSystematic review intro for librarians
Systematic review intro for librarians
Son Nghiem
 
Statistical Writing. Tables and Figures (Sven Sandin)
Statistical Writing. Tables and Figures (Sven Sandin)Statistical Writing. Tables and Figures (Sven Sandin)
Statistical Writing. Tables and Figures (Sven Sandin)
kgr023
 
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
healthlibaust2012
 
Introduction to Systematic Reviews
Introduction to Systematic ReviewsIntroduction to Systematic Reviews
Introduction to Systematic Reviews
Laura Koltutsky
 
ICH GCP
ICH GCPICH GCP

Viewers also liked (19)

Epinor abstract book 2014
Epinor abstract book 2014Epinor abstract book 2014
Epinor abstract book 2014
 
Statistical Writing (Sven Sandin)
Statistical Writing (Sven Sandin)Statistical Writing (Sven Sandin)
Statistical Writing (Sven Sandin)
 
Como hacer un avatar
Como hacer un avatarComo hacer un avatar
Como hacer un avatar
 
Gnst 313 Winter09
Gnst 313 Winter09Gnst 313 Winter09
Gnst 313 Winter09
 
Information retrieval in systematic reviews: a case study of the crime preven...
Information retrieval in systematic reviews: a case study of the crime preven...Information retrieval in systematic reviews: a case study of the crime preven...
Information retrieval in systematic reviews: a case study of the crime preven...
 
Cochrane Collaboration - Register of Studies Consultation
Cochrane Collaboration - Register of Studies ConsultationCochrane Collaboration - Register of Studies Consultation
Cochrane Collaboration - Register of Studies Consultation
 
The Cochrane Collaboration
The Cochrane CollaborationThe Cochrane Collaboration
The Cochrane Collaboration
 
1. Opening of the Austrian Cochrane Branch - Iain Chalmers
1. Opening of the Austrian Cochrane Branch - Iain Chalmers1. Opening of the Austrian Cochrane Branch - Iain Chalmers
1. Opening of the Austrian Cochrane Branch - Iain Chalmers
 
Systematic review searches
Systematic review searchesSystematic review searches
Systematic review searches
 
Study Eligibility Criteria
Study Eligibility CriteriaStudy Eligibility Criteria
Study Eligibility Criteria
 
A mid flight correction: setting priorities
A mid flight correction: setting prioritiesA mid flight correction: setting priorities
A mid flight correction: setting priorities
 
Exhaustive Literature Searching (Systematic Reviews)
Exhaustive Literature Searching (Systematic Reviews)Exhaustive Literature Searching (Systematic Reviews)
Exhaustive Literature Searching (Systematic Reviews)
 
Crowdsourcing and Cochrane
Crowdsourcing and CochraneCrowdsourcing and Cochrane
Crowdsourcing and Cochrane
 
Systematic review intro for librarians
Systematic review intro for librariansSystematic review intro for librarians
Systematic review intro for librarians
 
Statistical Writing. Tables and Figures (Sven Sandin)
Statistical Writing. Tables and Figures (Sven Sandin)Statistical Writing. Tables and Figures (Sven Sandin)
Statistical Writing. Tables and Figures (Sven Sandin)
 
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
 
Introduction to Systematic Reviews
Introduction to Systematic ReviewsIntroduction to Systematic Reviews
Introduction to Systematic Reviews
 
Principle of good clinical practice
Principle of good clinical practicePrinciple of good clinical practice
Principle of good clinical practice
 
ICH GCP
ICH GCPICH GCP
ICH GCP
 

Similar to PROSPERO: an international prospective register of systematic review protocols

Reporting guidelines
Reporting guidelinesReporting guidelines
Reporting guidelines
Dr. Avishek Amar
 
Project management in clinical research sanjay akhani 8 may
Project management in clinical research sanjay akhani 8 mayProject management in clinical research sanjay akhani 8 may
Project management in clinical research sanjay akhani 8 maySanjay Akhani
 
The new Evaluation Methodology
The new Evaluation MethodologyThe new Evaluation Methodology
The new Evaluation Methodology
MEYS, MŠMT in Czech
 
Evaluating Systems Change
Evaluating Systems ChangeEvaluating Systems Change
Evaluating Systems Change
Noel Hatch
 
Data Extraction for Systematic Reviews - Dr Ekpereonne Esu
Data Extraction for Systematic Reviews - Dr Ekpereonne EsuData Extraction for Systematic Reviews - Dr Ekpereonne Esu
Data Extraction for Systematic Reviews - Dr Ekpereonne Esu
ACSRM
 
Introduction to clinical research
Introduction to clinical researchIntroduction to clinical research
Introduction to clinical research
Anor Abidin
 
DATA MANAGEMENT PLAN on clinical research .pptx
DATA MANAGEMENT PLAN on clinical research .pptxDATA MANAGEMENT PLAN on clinical research .pptx
DATA MANAGEMENT PLAN on clinical research .pptx
Aneesha0316
 
Protocol Writing in Clinical Research
Protocol Writing in Clinical ResearchProtocol Writing in Clinical Research
Protocol Writing in Clinical Research
ClinosolIndia
 
Data Management Plan of Clinical Research pptx
Data Management Plan of Clinical Research pptxData Management Plan of Clinical Research pptx
Data Management Plan of Clinical Research pptx
Aneesha0316
 
Organizational Capacity-Building Series - Session 6: Program Evaluation
Organizational Capacity-Building Series - Session 6: Program EvaluationOrganizational Capacity-Building Series - Session 6: Program Evaluation
Organizational Capacity-Building Series - Session 6: Program Evaluation
INGENAES
 
Webinar on eTMF – Challenges, Opportunities & Trends
Webinar on eTMF – Challenges, Opportunities & TrendsWebinar on eTMF – Challenges, Opportunities & Trends
Webinar on eTMF – Challenges, Opportunities & Trends
nancykathlen
 
Lies, Damned Lies and Cost-Effectiveness: Open-Source Models
Lies, Damned Lies and Cost-Effectiveness: Open-Source ModelsLies, Damned Lies and Cost-Effectiveness: Open-Source Models
Lies, Damned Lies and Cost-Effectiveness: Open-Source Models
Office of Health Economics
 
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Bhaswat Chakraborty
 
Adewonuola resume
Adewonuola resumeAdewonuola resume
Adewonuola resume
AdewonuolaAjibade
 
Digital Scholar Webinar: Understanding and using PROSPERO: International pros...
Digital Scholar Webinar: Understanding and using PROSPERO: International pros...Digital Scholar Webinar: Understanding and using PROSPERO: International pros...
Digital Scholar Webinar: Understanding and using PROSPERO: International pros...
SC CTSI at USC and CHLA
 
CLINICAL TRIAL REGISTRATION IN INDIA
CLINICAL TRIAL REGISTRATION  IN INDIACLINICAL TRIAL REGISTRATION  IN INDIA
CLINICAL TRIAL REGISTRATION IN INDIA
Rohit K.
 
Operational research dr ajay tyagi
Operational research dr ajay tyagiOperational research dr ajay tyagi
Operational research dr ajay tyagi
Drajay Tyagi
 
Impacting Recruitment from a Sponsor / CRO Perspective
Impacting Recruitment from a Sponsor / CRO PerspectiveImpacting Recruitment from a Sponsor / CRO Perspective
Impacting Recruitment from a Sponsor / CRO Perspective
Fraser Gibson
 
GPC Treatment Switching in Oncology Trials Initiative Overview
GPC Treatment Switching in Oncology Trials Initiative OverviewGPC Treatment Switching in Oncology Trials Initiative Overview
GPC Treatment Switching in Oncology Trials Initiative Overview
Center for Medical Technology Policy
 

Similar to PROSPERO: an international prospective register of systematic review protocols (20)

Reporting guidelines
Reporting guidelinesReporting guidelines
Reporting guidelines
 
Spirit 2013
Spirit 2013Spirit 2013
Spirit 2013
 
Project management in clinical research sanjay akhani 8 may
Project management in clinical research sanjay akhani 8 mayProject management in clinical research sanjay akhani 8 may
Project management in clinical research sanjay akhani 8 may
 
The new Evaluation Methodology
The new Evaluation MethodologyThe new Evaluation Methodology
The new Evaluation Methodology
 
Evaluating Systems Change
Evaluating Systems ChangeEvaluating Systems Change
Evaluating Systems Change
 
Data Extraction for Systematic Reviews - Dr Ekpereonne Esu
Data Extraction for Systematic Reviews - Dr Ekpereonne EsuData Extraction for Systematic Reviews - Dr Ekpereonne Esu
Data Extraction for Systematic Reviews - Dr Ekpereonne Esu
 
Introduction to clinical research
Introduction to clinical researchIntroduction to clinical research
Introduction to clinical research
 
DATA MANAGEMENT PLAN on clinical research .pptx
DATA MANAGEMENT PLAN on clinical research .pptxDATA MANAGEMENT PLAN on clinical research .pptx
DATA MANAGEMENT PLAN on clinical research .pptx
 
Protocol Writing in Clinical Research
Protocol Writing in Clinical ResearchProtocol Writing in Clinical Research
Protocol Writing in Clinical Research
 
Data Management Plan of Clinical Research pptx
Data Management Plan of Clinical Research pptxData Management Plan of Clinical Research pptx
Data Management Plan of Clinical Research pptx
 
Organizational Capacity-Building Series - Session 6: Program Evaluation
Organizational Capacity-Building Series - Session 6: Program EvaluationOrganizational Capacity-Building Series - Session 6: Program Evaluation
Organizational Capacity-Building Series - Session 6: Program Evaluation
 
Webinar on eTMF – Challenges, Opportunities & Trends
Webinar on eTMF – Challenges, Opportunities & TrendsWebinar on eTMF – Challenges, Opportunities & Trends
Webinar on eTMF – Challenges, Opportunities & Trends
 
Lies, Damned Lies and Cost-Effectiveness: Open-Source Models
Lies, Damned Lies and Cost-Effectiveness: Open-Source ModelsLies, Damned Lies and Cost-Effectiveness: Open-Source Models
Lies, Damned Lies and Cost-Effectiveness: Open-Source Models
 
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
 
Adewonuola resume
Adewonuola resumeAdewonuola resume
Adewonuola resume
 
Digital Scholar Webinar: Understanding and using PROSPERO: International pros...
Digital Scholar Webinar: Understanding and using PROSPERO: International pros...Digital Scholar Webinar: Understanding and using PROSPERO: International pros...
Digital Scholar Webinar: Understanding and using PROSPERO: International pros...
 
CLINICAL TRIAL REGISTRATION IN INDIA
CLINICAL TRIAL REGISTRATION  IN INDIACLINICAL TRIAL REGISTRATION  IN INDIA
CLINICAL TRIAL REGISTRATION IN INDIA
 
Operational research dr ajay tyagi
Operational research dr ajay tyagiOperational research dr ajay tyagi
Operational research dr ajay tyagi
 
Impacting Recruitment from a Sponsor / CRO Perspective
Impacting Recruitment from a Sponsor / CRO PerspectiveImpacting Recruitment from a Sponsor / CRO Perspective
Impacting Recruitment from a Sponsor / CRO Perspective
 
GPC Treatment Switching in Oncology Trials Initiative Overview
GPC Treatment Switching in Oncology Trials Initiative OverviewGPC Treatment Switching in Oncology Trials Initiative Overview
GPC Treatment Switching in Oncology Trials Initiative Overview
 

More from HTAi Bilbao 2012

How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment?  An Elicit...How Glaucoma Patients Assess Different Aspects of Their Treatment?  An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...
HTAi Bilbao 2012
 
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
HTAi Bilbao 2012
 
Health Technology Assessment (HTA) Report: Interventions to increase particip...
Health Technology Assessment (HTA) Report: Interventions to increase particip...Health Technology Assessment (HTA) Report: Interventions to increase particip...
Health Technology Assessment (HTA) Report: Interventions to increase particip...
HTAi Bilbao 2012
 
The use of ‘colloquial evidence’ in HTA: the experience of NICE
The use of ‘colloquial evidence’ in HTA:  the experience of NICE The use of ‘colloquial evidence’ in HTA:  the experience of NICE
The use of ‘colloquial evidence’ in HTA: the experience of NICE
HTAi Bilbao 2012
 
Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ens...Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ens...
HTAi Bilbao 2012
 
Challenges in commissioning research on what works in integrated care
Challenges in commissioning research on what works in integrated careChallenges in commissioning research on what works in integrated care
Challenges in commissioning research on what works in integrated care
HTAi Bilbao 2012
 
Building a portfolio of research findings for use by healthcare managers and ...
Building a portfolio of research findings for use by healthcare managers and ...Building a portfolio of research findings for use by healthcare managers and ...
Building a portfolio of research findings for use by healthcare managers and ...
HTAi Bilbao 2012
 
Assessing the International Use
Assessing the International Use Assessing the International Use
Assessing the International Use HTAi Bilbao 2012
 
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
HTAi Bilbao 2012
 
On the outside looking in.
On the outside looking in. On the outside looking in.
On the outside looking in.
HTAi Bilbao 2012
 
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
HTAi Bilbao 2012
 
How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatme...How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatme...
HTAi Bilbao 2012
 
The eunethta planned and ongoing projects database
The eunethta planned and ongoing projects databaseThe eunethta planned and ongoing projects database
The eunethta planned and ongoing projects database
HTAi Bilbao 2012
 
Evaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' supportEvaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' support
HTAi Bilbao 2012
 
Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual tech...Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual tech...
HTAi Bilbao 2012
 
Bevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degenerationBevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degeneration
HTAi Bilbao 2012
 
Azienda ospedaliero Universitaria of Udine
Azienda ospedaliero Universitaria of UdineAzienda ospedaliero Universitaria of Udine
Azienda ospedaliero Universitaria of Udine
HTAi Bilbao 2012
 
HTAi in hospitals
HTAi in hospitalsHTAi in hospitals
HTAi in hospitals
HTAi Bilbao 2012
 
The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...
HTAi Bilbao 2012
 
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
HTAi Bilbao 2012
 

More from HTAi Bilbao 2012 (20)

How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment?  An Elicit...How Glaucoma Patients Assess Different Aspects of Their Treatment?  An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...
 
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
 
Health Technology Assessment (HTA) Report: Interventions to increase particip...
Health Technology Assessment (HTA) Report: Interventions to increase particip...Health Technology Assessment (HTA) Report: Interventions to increase particip...
Health Technology Assessment (HTA) Report: Interventions to increase particip...
 
The use of ‘colloquial evidence’ in HTA: the experience of NICE
The use of ‘colloquial evidence’ in HTA:  the experience of NICE The use of ‘colloquial evidence’ in HTA:  the experience of NICE
The use of ‘colloquial evidence’ in HTA: the experience of NICE
 
Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ens...Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ens...
 
Challenges in commissioning research on what works in integrated care
Challenges in commissioning research on what works in integrated careChallenges in commissioning research on what works in integrated care
Challenges in commissioning research on what works in integrated care
 
Building a portfolio of research findings for use by healthcare managers and ...
Building a portfolio of research findings for use by healthcare managers and ...Building a portfolio of research findings for use by healthcare managers and ...
Building a portfolio of research findings for use by healthcare managers and ...
 
Assessing the International Use
Assessing the International Use Assessing the International Use
Assessing the International Use
 
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
 
On the outside looking in.
On the outside looking in. On the outside looking in.
On the outside looking in.
 
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
 
How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatme...How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatme...
 
The eunethta planned and ongoing projects database
The eunethta planned and ongoing projects databaseThe eunethta planned and ongoing projects database
The eunethta planned and ongoing projects database
 
Evaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' supportEvaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' support
 
Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual tech...Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual tech...
 
Bevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degenerationBevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degeneration
 
Azienda ospedaliero Universitaria of Udine
Azienda ospedaliero Universitaria of UdineAzienda ospedaliero Universitaria of Udine
Azienda ospedaliero Universitaria of Udine
 
HTAi in hospitals
HTAi in hospitalsHTAi in hospitals
HTAi in hospitals
 
The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...
 
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
 

Recently uploaded

Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYDISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
NEHA GUPTA
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Management of Traumatic Splenic injury.pptx
Management of Traumatic Splenic injury.pptxManagement of Traumatic Splenic injury.pptx
Management of Traumatic Splenic injury.pptx
AkshaySarraf1
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 

Recently uploaded (20)

Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYDISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Management of Traumatic Splenic injury.pptx
Management of Traumatic Splenic injury.pptxManagement of Traumatic Splenic injury.pptx
Management of Traumatic Splenic injury.pptx
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 

PROSPERO: an international prospective register of systematic review protocols

  • 1. PROSPERO: an international prospective register of systematic review protocols Alison Booth Mike Clarke Davina Ghersi David Moher Mark Petticrew Lesley Stewart
  • 2. Prospective registration of systematic review protocols • PRISMA 2009 advocated registration • CRD initiated development of PROSPERO • PROSPERO launched 2011 • Until then no open access facility to formally register systematic review protocols • Although publication of protocols is integral to Cochrane and Campbell Collaborations this is limited to their own organisations
  • 3. Why register systematic reviews • Widely accepted (& promoted) that systematic reviews provide best evidence for decision making • Have the potential to impact on decisions that affect the care of many people and to have significant budgetary impact • Associated responsibility to ensure best methods and conduct to ensure systematic reviews are robust and free from bias
  • 4. Avoiding bias • Detecting and mitigating bias in included studies is central to systematic review. Influences and pressures on reporting are the same for systematic reviews as for clinical trials • Systematic review protocols ensure review methods are transparent and reproducible. Adherence to the protocol should help avoid bias • Changes in emphasis between protocol and completed review have potential to bias review findings • Evidence that reviews change between protocol and final report (Silagy et al JAMA 2002) and of outcome reporting biases (Kirkham et al PLoS ONE 2010)
  • 5. Registration can help • Permanent public record of key elements of planned review including inclusion criteria and outcomes • Allows amendments and maintains audit trail of changes (not unreasonable to make changes, but need to know why) • Allows published results to be compared with what was planned at protocol registration and judgement of whether any discrepancies might have introduced bias
  • 6. Avoiding bias • Registration in PROSPERO takes place when the protocol is finalised but ideally before eligibility screening has started • Reduces opportunity for post-hoc „tweaking‟ • Recognise that it will not stop deliberate „cheating‟ • PROSPERO openly displays dates and amendments • Does not in itself prevent overt misuse • Falsification would be deliberate act of scientific misconduct with potentially serious and damaging consequences
  • 7. Avoiding unintended duplication • Systematic reviews can be time consuming and costly • Often duplicate or very similar reviews are undertaken • Unintended duplication is economically wasteful • Commissioners and researchers may be unaware of ongoing reviews and/or unpublished reviews
  • 8. How registration can help • Registration should allow those planning reviews to check whether there are any reviews already in the „pipeline‟ or completed but unpublished that address their topic of interest • They can then decide whether or not to proceed
  • 9. Benefits to stakeholders Researchers • Comply with PRISMA • Provide a public record of their planned methods • Raise awareness of their review • Unique registration number may help track subsequent use of their review and monitor impact Commissioners and funders • Identify ongoing and unpublished reviews • Avoid unplanned duplication and economic wastefulness
  • 10. Benefits to stakeholders Guideline developers • Information about forthcoming reviews may assist in planning and timing of guideline development Journal Editors • Safeguard against reporting biases • Access to key protocol features to utilise in peer review Peer reviewers • Comparison of manuscript findings with the review protocol
  • 11. Benefits to stakeholders Methodologists • Provides opportunity for methods research The public • Helps ensure that health and social care decisions that may affect them are known to be based on good quality systematic review evidence • Open access information about ongoing systematic reviews • Encourages transparency in the systematic review process • Helping to avoid wasting money on unintended duplication
  • 12. PROSPERO implementation Aimed to make registration as straightforward as possible: • Web based • Free to register, free to search • Researchers create and update their own records • Record content is responsibility of researcher/ review author • Administrators check for “sense” not peer review • Issues unique registration number • An audit trail of amendments is maintained • Registration record indexed by the PROSPERO team • Based on data set agreed by international consultation: 22 required fields 18 optional fields
  • 13.
  • 14. Registering a review www.crd.york.ac.uk/PROSPERO Current scope Systematic reviews of the effects of interventions and strategies to prevent, diagnose, treat, and monitor health conditions, for which there is a health related outcome
  • 15.
  • 16. PROSPERO • Since launch almost 600 reviews registered undertaken in 34 different countries • Over 15,000 visitors and over a million page views in first year
  • 17. Registration makes sense • Promotes transparency and helps identify and reduce risk of reporting bias • Helps avoid unintended duplication and supports research funding to be used wisely and to best effect • Requires modest additional effort and early success of PROSPERO indicates researchers are ready and willing to register their systematic review protocols • Prospective registration should become standard best practice for those who commission, fund and conduct systematic reviews
  • 18. Thank you The development and ongoing management of PROSPERO is supported by CRD‟s core work programme which is funded by the National Institute for Health Research, England; the Department of Health, Public Health Agency, Northern Ireland and the National Institute for Social Care and Health Research, Welsh Government. www.crd.york.ac.uk/PROSPERO crd-register@york.ac.uk
  • 19. Registration minimum dataset 22 required fields: Administrative Review design • Review title • Review question/objective • Named contact(s) • Condition/domain studied • Contact e-mail • Search details • Organisational affiliation • Participants/population • Funding source/sponsors • Intervention/exposure • Conflict of interests • Comparator/control • Anticipated or actual start date • Study types • Stage of review† • Primary outcomes • Anticipated completion date • Secondary outcomes • Review status† • Risk of bias/quality assessment • Strategy for data synthesis † these fields are updated as the review progresses • Planned subgroup analyses
  • 20. Registration dataset 18 optional fields: Administrative Review design • Contact postal address • Type of review • Contact phone number • URL to search strategy • Review team members & affiliations • URL to full protocol • Collaborators • Context • Other registration details • Data extraction methods • Organisational reference number • Dissemination plan • Language • Link to final report/publication (added • Country over time) • Key words • Any other information Italics denote functional fields not • Existing review by same authors decided by consultation exercise